Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKelso Grp Hldg Regulatory News (KLSO)

Share Price Information for Kelso Grp Hldg (KLSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.75
Bid: 2.50
Ask: 3.00
Change: -0.05 (-1.79%)
Spread: 0.50 (20.00%)
Open: 2.80
High: 0.00
Low: 0.00
Prev. Close: 2.80
KLSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results for six months ended 30 June 2023

28 Sep 2023 07:00

RNS Number : 8978N
Kelso Group Holdings PLC
28 September 2023
 

Kelso Group Holdings Plc ("Kelso" or the "Company")

A highly concentrated investor in UK small and mid-cap listed companies. Driving value enhancement through active engagement

Interim results for the six months ended 30 June 2023

 

Kelso, the main market listed investment company, is pleased to announce its consolidated unaudited interim results for the six months ended 30 June 2023.

Highlights

· Raised £6.0 million in two placings of £3.0 million each at 2.0p and 2.5p

· NAV/share increased by 267% to 2.2p as at 30 June 2023 (0.6p 31 December 2022)

· Significant net investment of £5.0 million at an average cost of 63.1p, in THG plc ("THG"), resulting in a gross realised and unrealised gain on investments of £1.76 million, a return of c.35%

· Net profit, after expenses and accrued tax and MIP costs, of £1.0 million

· Post period end:

sale of 1.5 million THG shares at a price of 105p, leading to a gross profit of c£0.6 million, as we broaden the portfolio

investment in TheWorks.co.uk plc ("TheWorks") of 2.9 million shares at an average price of 33.4p. Current price is c.37.25p

Chairman's statement, Sir Nigel Knowles

I am delighted to have been appointed as Chairman to Kelso in January this year, with David Charters' appointment as a Non-Executive Director following soon after. I share the ambition of the executive directors to build Kelso into a sizeable investment vehicle operating in the listed UK small/mid cap arena and firmly believe that there is a significant opportunity for Kelso to achieve outsized returns by investing in a highly focussed and select number of undervalued companies, creating value through active engagement. The team applies a robust and rigorous approach to analysis and due diligence to arrive at these high conviction investments. With this concentrated focus, the team is able to commit significant resource, working alongside key stakeholders, to drive actions that enhance shareholder value.

 

The UK market, especially at the smaller end, has many examples of extreme value. On any number of valuation metrics, the UK small cap market trades at a significant discount to the US, the Rest of the World, or even the UK large cap market, yet growth rates and returns outperform over the longer term. I believe our latest investment in TheWorks, at 1.2x EV/EBITDA (excluding IFRS 16 lease liabilities), clearly demonstrates that, as we target annualised returns of at least 25%, but aim for significantly in excess of that. Furthermore, due to the UK value discrepancy, particularly pronounced at the smaller end of the market, many quality UK companies are the targets of private equity or corporate takeovers. Kelso's aim is to capitalise on these opportunities.

 

In the medium term, we aim to grow our investment business which is prepared to work actively with portfolio companies to help them create value for their shareholders, by both challenging but also supporting their strategies.

 

I would like to thank all our shareholders, many of whom are successful business managers and founders. We really value shareholder support, and I would like to thank them for this and for the many investment ideas received to date.

 

Chief Executive Review, John Goold

I am pleased to report on Kelso's first interim results for the six months to 30 June 2023. In this period, we announced an expansion of the Board, completed two placings totalling £6.0 million, achieved a first half profit, net of accrued tax and performance fees, of £1.0 million and increased our NAV/share from 0.6p to 2.2p.

 

Our H1 profit and loss account shows a gross gain on investment of £1.76 million of which £1.47 million was unrealised and £0.29 million was realised. Following the post period end disposal of 1.5 million THG shares at 105p we now hold 6.5 million shares in THG, valued at the period end price of 81.5p. As we release these interim results, we note that THG's share price is c.76.2p (versus our average in price of 63.1p including financing), however, as mentioned in a number of our previous announcements, we are confident that the underlying inherent value will in time be reflected in the share price.

 

The major cost relates to staff costs of £244k which is entirely a non-cash provision for the long-term management incentive plan, details of which have been outlined previously. The MIP is aligned with shareholders and obviously if the value of our investments, and ultimately shareholder returns, reduce then this provision would reduce. The scheme crystallises 3-5 years after inception and is fully paid in Kelso shares rather than cash. For the period, the Directors received no salary and there were no property costs; the board holds 21% of the share capital of Kelso. The other costs of audit and accountancy of £61k, professional costs of £59k and £37k of administrative costs are for the ongoing running of the business which we continue to keep to a minimum.

 

We made our inaugural investment in THG during the period, holding 8.0 million shares at an average cost of 63.1p with a mixture of cash and CFDs. We announced our investment thesis for THG, highlighting the significant value, based on a sum of the parts, that is, in our view, clearly inherent within the business. We also set out in a public statement what we felt THG needed to do to realise the value lost to shareholders since IPO. THG's share price has certainly shown significant volatility, rising and sinking over c.30-50% twice during the period. After our purchases at an average price of 63.1p, the shares rallied to almost 120p following an approach from Apollo, fell back to a low of 57p when the approach was rejected, rallied again to a peak of 92p as shareholders anticipated strong interim results and subsequently fell to 67p (after 30 June 2023), when THG's interim results did not fulfil hopes of or articulate their investment strategy. We believe that management need to manage communications around the high-level strategy and future structure of the business and hence reduce such volatility, and work towards a break-up of the group alongside a move to the Premium Index of the Official List. We are supportive of the Board's improvements around governance and believe reduction in the price of whey will lead to a much more positive H2 trading position.

 

Post period end, we trimmed our position in THG as we look for new investments and broaden the portfolio, by selling 1.5 million shares at 105p generating a realised gain of c.£0.6 million being a cash return on these shares of c.67%. Furthermore, we made our second investment, in TheWorks, now holding 2.9 million shares at an average price of 33.0p. TheWorks is the UK's leading family friendly retailer of value gifts, arts and crafts, toys and books with 12 of its own brands (c.25%-30% of revenue) through 525 retail outlets. TheWorks was floated in July 2018 at a value of £100 million and a share price of 160p. Broker forecasts, for the year to 30 April 2024, are for revenue of £294 million, EBITDA of £10 million and net cash of £10 million (both on a pre-IFRS 16 basis). We invested at a market cap of 22.3 million, a valuation of 1.2x EV/EBITDA. We are supportive of the Board and their strategy but believe that, on such a low valuation, the company should be buying back their shares rather than paying dividends. Accordingly, we have voted against the proposed final dividend at the company's AGM on 4 October 2023 and will encourage the company to pursue a buy back strategy. We voted in favour of all the other resolutions.

 

Kelso will only invest in a handful of investments at this stage of our development. With our second investment now announced, we are building our third investment and aim to start investing in a further company shortly. Although there is value at the smaller end of the market, finding liquidity is often not straight forward and there is a dearth of sellers which bodes well for future price movements. Value opportunities with significant potential capital growth, especially with some positive activist engagement, remain plentiful. The Kelso team is working well together, and we are receiving an increased number of investment ideas from our shareholders, UK institutions and market contacts.

 

I would like to reiterate our Chairman's words of gratitude to those many shareholders who have supported us and backed Kelso at this early stage. We continue to welcome investment ideas for situations where we can enable change in UK listed companies to unlock trapped value.

 

Responsibility statement

We confirm that to the best of our knowledge:

(a) the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

(b) the interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

(c) the interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).

Principal Risks and Uncertainties

The principal risks and uncertainties affecting the business activities of the Company remain those detailed in the Annual Report and Accounts 2022, a copy of which is available on the Company website at www.kelsoplc.com.

Additional principal risks and uncertainties arising since the year end are listed below:

Portfolio risk

The Company invested in listed shares in the period. In doing so, the group's investments are not diversified and is exposed to market fluctuations. Management closely monitors the market price of their investment to minimise adverse risk and are monitoring the stock market for opportunities to diversify the portfolio.

Contract For Differences risk

The Company invested in Contract For Differences (CFD) in the period. Management is experienced in CFD trading and have chosen a highly respected CFD provider to minimise counterparty risks or delays.

The Board considers that these remain a current reflection of the risks and uncertainties facing the business for the remaining six months of the financial year.

 

For further information please contact:

Kelso Group Holdings plc

+44 (0) 75 4033 3933

John Goold, Chief Executive Officer

Mark Kirkland, Chief Financial Officer

Jamie Brooke, Chief Investment Officer

Zeus (Broker)

+44 (0) 20 3829 5000

Nick Cowles, Ed Beddows (Investment Banking)

Ben Robertson (Corporate Broking)

 

 

Consolidated Statement of Comprehensive Income

For the six months ended 30 June 2023 (Unaudited)

 

 

Note

6 months ended

30 June 2023

6 months ended

30 June 2022

12 months ended 31 December 2022

 

(unaudited)

(unaudited)

(audited)

 

£

£

£

 

 

 

Revenue

 

 

Gains on investments

5

1,760,358

-

-

 

 

Administrative expenses

 

Staff costs (relating to MIP)

13

(243,671)

-

-

Audit and accountancy fees

(61,116)

(10,750)

(24,163)

Professional costs

(59,398)

(25,391)

(159,972)

Other administrative expenses

(36,938)

(20,819)

(103,722)

Profit /(Loss) from operations

1,359,235

(56,960)

(287,857)

 

 

 

Finance expenses

(63,447)

-

(1,467)

 

Profit /(Loss) before taxation

1,295,788

(56,960)

(289,324)

 

 

 

Income tax

(259,625)

-

-

 

 

Profit /(Loss) for the period

 

1,036,163

(56,960)

(289,324)

 

 

 

Basic and diluted gain/(loss) per share (pence) 6

0.33

(0.12)

(0.61)

 

 

 

 

 

 

Basic and diluted earnings /(Loss) per share from continuing operations (pence)

0.33

(0.12)

(0.61)

 

 

 

Consolidated Balance Sheet

As at 30 June 2023 (Unaudited)

 

As at

As at

As at

 

30 June

30 June

31 December

2023

2022

2022

Note

(unaudited)

(unaudited)

(audited)

£

£

£

Assets

 

 

 

Current

Investments

9

6,520,000

-

-

Trade and other receivables

8,497

92,441

9,006

Cash and cash equivalents

3,080,953

439,922

332,971

 

Total assets

9,609,450

532,363

341,977

 

 

Liabilities

Current

Trade and other payables

10

(198,028)

(2,220)

(44,198)

Non-current

Other payables

11

(2,156,768)

-

-

Deferred tax liabilities

(259,625)

-

-

Total liabilities

(2,614,421)

(2,220)

(44,198)

 

 

Net assets

6,995,029

530,143

297,779

 

 

 

 

Equity

Share capital

12

3,175,250

475,250

475,250

Share Premium Reserve

3,240,077

320,150

320,150

Retained Profit/ (Loss)

538,542

(265,257)

(497,621)

Equity attributable to owners of the Group

6,953,869

530,143

297,779

Non-controlling interest

13

41,160

-

-

Total equity

6,995,029

530,143

297,779

 

 

 

 

Net asset value per share

2.2p

1.1p

0.6p

Consolidated Changes in Equity

As at 30 June 2023 (Unaudited) 

Share Capital

Share Premium

Retained Earnings

Total attributable to owners of parent

NCI

Total Equity

 

 

 

 

 

 

 

£

£

£

£

£

£

At 1 January 2022

475,250

320,150

(208,297)

587,103

-

587,103

Comprehensive income for the period

Loss for the period

-

-

(56,960)

(56,960)

-

(56,960)

Total comprehensive income for the period

-

-

(56,960)

(56,960)

-

(56,960)

At 30 June 2022

475,250

320,150

(265,257)

530,143

-

530,143

Comprehensive income for the period

 

 

 

 

 

 

Loss for the period

-

-

(232,364)

(232,364)

-

(232,364)

Total comprehensive income for the period

-

-

(232,364)

(232,364)

-

(232,364)

At 31 December 2022

475,250

320,150

(497,621)

297,779

-

297,779

Comprehensive income for the period

 

 

 

 

 

 

Profit for the period

-

-

1,036,163

1,036,163

-

1,036,163

Total comprehensive income for the period

-

-

1,036,163

1,036,163

-

1,036,163

Transaction with owners

Issue of Share Capital

2,700,000

2,919,927

-

5,619,927

41,160

5,661,087

Total transactions with owners

2,700,000

2,919,927

-

5,619,927

41,160

5,661,087

At 30 June 2023

3,175,250

3,240,077

538,542

6,953,869

41,160

6,995,029

 

 

Consolidated Statement of Cash Flows

 

As at 30 June 2023 (Unaudited)

 

As at

As at

As at

 

30 June

30 June

31 December

 

2023

2022

2022

 

(unaudited)

(unaudited)

(audited)

 

£

£

£

Cash flows from operating activities

 

Profit/(Loss) for the period

1,036,163

(56,960)

(289,324)

Unrealised gain on investments

(1,472,133)

-

-

Realised gain on investment

(288,225)

-

-

Increase in MIP provision

243,671

-

-

Corporation/deferred tax

259,625

-

-

Finance expenses paid

63,447

 -

1,467

(157,452)

(56,960)

(287,857)

Movement in working capital:

 

Decrease/(increase) in trade and other receivables

(2,800)

(44,852)

38,583

Increase/ (Decrease) in trade and other payables

157,140

(34,288)

7,690

Cash generated from operations

 

(3,112)

(136,100)

(241,584)

Net cash used in operating activities

 

(3,112)

(136,100)

(241,584)

Financing activities

 

Acquisition of investments

(4,361,074)

-

-

Disposal of investments

1,514,528

-

-

Issue of shares

5,619,927

-

-

Issue of shares - non-controlling interest

41,160

-

-

Finance costs

(63,447)

-

(1,467)

Net cash used in financing activities

 

2,751,094

-

(1,467)

Net cash (decrease)/increase in cash and cash equivalents

 

2,747,982

(136,100)

(243,051)

Cash and cash equivalents at the beginning of period

332,971

576,022

576,022

Cash and cash equivalents at the end of the period

 

3,080,953

439,922

332,971

 

Notes to the interim results

 

1. Basis of preparation

Kelso Group Holdings Plc is a public limited company incorporated in the United Kingdom under the Companies Act 2006 (registration number:11504186). The Company's ordinary shares are admitted to trading on the main market of the London Stock Exchange.

These interim financial statements for the six months ended 30 June 2023 should be read in conjunction with the financial statements for the year ended 31 December 2022, which have been prepared in accordance with International Financial Reporting Standards ("IFRSs") as applied in accordance with the provisions of the Companies Act 2006. The interim report and accounts do not include all the information and disclosures required in the annual financial statements. 

 

2. Significant accounting policies

The interim report and accounts have been prepared in accordance with IAS34 (Interim Financial Statements) and on the basis of the accounting policies, presentation and methods of computation as set out in the Company's December 2022 Annual Report and Accounts, except for those that relate to new standards and interpretations effective for the first time for periods beginning on (or after) 1 January 2023 and will be adopted in the 2023 annual financial statements. 

The financial information is presented in Pounds Sterling, rounded to the nearest pound and has been prepared under the historical cost convention.

The interim report and accounts do not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. These interim financial statements were approved by the Board of Directors on 27 September 2023. The results for the six months to 30 June 2023 and the comparative results for the six months to 30 June 2022 are unaudited. The figures for the year ended 31 December 2022 are extracted from the audited statutory accounts of the Company for that period.

 

3. New accounting standards adopted at 1 January 2023

There are no significant pronouncements which have become effective from 1 January 2023 that have a significant impact on the Group's interim condensed consolidated financial statements.

 

4. Estimates and judgements

When preparing the Interim Financial Statements, management undertakes a number of judgements, estimates and assumptions about recognition and measurement of assets, liabilities, income and expenses. The actual results may differ from the judgements, estimates and assumptions made by management, and will seldom equal the estimated results.

The judgements, estimates and assumptions applied in the Interim Financial Statements, including the key sources of estimation uncertainty, were the same as those applied in the Group's last annual financial statements for the year ended 31 December 2022.

 

5. Revenue

Revenue represents realised and unrealised gains on investments.

6 months ended

30 June 2023

(Unaudited)

6 months ended

30 June 2022

(Unaudited)

12 months ended 31 December 2022

(Audited)

Realised gains

288,225

-

-

Unrealised gains

1,472,133

-

-

Total gains

1,760,358

-

-

 

Realised gains were due to a switch in the THG holding from the cash account to the CFD account.

 

6. Profit/(Loss) per share

Basic Profit/l(Loss) per share is calculated by dividing the Profit/(Loss) attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the period. There are currently no share options in issue.

6 months ended

30 June 2023

6 months ended

30 June 2022

12 months ended 31 December 2022

(unaudited)

(unaudited)

(audited)

Profit/(loss) from operations

£

1,036,163

(56,960)

(289,324)

Weighted average number of shares

317,525,000

47,525,000

47,525,000

Basic and Diluted profit/(loss) per share

Pence

0.33

(0.12)

(0.61)

 

7. Taxation

 

 

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. These have been applied on both realised and unrealised profits.

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Deferred tax liability has been provided in line with reported profits in current reporting period net of past tax losses.

 

 

8. Events after the reporting period

 

After the period end, the Company disposed of 1.5 million THG shares realising a profit of c.£0.6 million, a c.67% uplift, and purchased 2.8 million shares in TheWorks at an average price of 33.4p, representing 4.7% of total issued share capital.

 

 

9. Investments

 

Fully paid shares

Shares acquired under CFD

Total

Additions

2,744,069

3,530,102

6,274,171

Disposal

(1,226,304)

-

(1,226,304)

Fair value adjustments

736,525

735,608

1,472,133

2,254,290

4,265,710

6,520,000

10. Current liabilities

 

30 June 2023

30 June 2022

31 December 2022

Trade creditors

163,810

-

9,173

Other taxes and social security

29,440

-

12,743

Other creditors

4,778

2,220

22,282

198,028

2,220

44,198

 

11. Non-current liabilities

 

30 June 2023

30 June 2022

31 December 2022

Investment funding

1,913,097

-

-

Other creditors

243,671

-

-

Deferred tax

259,625

-

-

2,416,393

-

-

 

At 30 June 2023, the market value of investments under CFD was £4,265,710, with leverage of £1,913,097. The equity value of the CFD account was £2,352,613 with cash held in the margin account of £2,005,000. Shares held under the CFD agreement are secured by way of first fixed charge on all instruments and related rights, including cash held in the linked share dealing account.

 

12. Share capital

On 24 January 2023, the Company issued 150,000,000 ordinary shares for cash for a value of £3,000,000 and on 24 March 2023 the Company issued an additional 120,000,000 ordinary shares for cash for a value of £3,000,000. The total number of ordinary shares in issue at 30 June 2023 was 317,525,000. All the shares have the same right to receive dividends and the repayment of capital and each share represents one vote at the shareholders' meeting on Kelso Group Holdings Plc.

 

13. Related Party Transactions

As stated in the Company's financial statements at 31 December 2022, a Management Incentive Plan ("MIP") has been established, at a cost to the participants of £41,160, in exchange for A shares in Kelso Ltd and based on the results for the six months to 30 June 2023, a provision in relation to the MIP of £243,671 was made for the period.

Other than the shares relating to the MIP, Kelso Ltd is a wholly owned subsidiary of Kelso Group Holdings Plc and acts as the main trading entity of the Group.

 

14. Distribution of Interim Reports

A copy of the interim report will be available shortly on the Group's website (www.kelsoplc.com)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR LRMFTMTJTBIJ
12
Date   Source Headline
8th May 202411:44 amRNSConfirmation of Accounts and Notice of AGM
8th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20247:02 amRNSFurther investment in NCC Group Plc
30th Apr 20247:00 amRNSFull-year results for 12 months ended 31 Dec 2023
4th Apr 20248:00 amRNSNotice of Results
14th Mar 20247:00 amRNSNotification of Major Holdings
14th Feb 20247:01 amRNSNED Appointments to The Works
14th Feb 20247:00 amRNSNotification of Major Holdings
30th Jan 20247:00 amRNSNotification of Major Holdings
25th Jan 20243:46 pmRNSNotification of Major Holdings
24th Jan 20243:10 pmRNSNotification of Major Holdings
22nd Jan 20247:00 amRNSAdmission of Placing Shares
16th Jan 20247:00 amRNSResult of fundraise
12th Jan 20247:00 amRNSTrading Update and Proposed Placing
15th Dec 20237:00 amRNSNotification of Major Holdings
7th Dec 20237:07 amRNSUpdate on THG Investment
4th Dec 20234:18 pmRNSNotification of Major Holdings
1st Dec 20237:00 amRNSNotification of major holdings
30th Nov 20237:00 amRNSNotification of Major Holdings
29th Nov 20231:13 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSAngling Direct Plc new investment
1st Nov 20233:20 pmRNSTransaction in Own Shares
30th Oct 20232:00 pmRNSTR-1: Notification of major holdings
30th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in Own Shares
11th Oct 20237:00 amRNSDirectorate Change
10th Oct 20237:00 amRNSInvestment in NCC Group Plc
5th Oct 20237:00 amRNSUpdate on Investment: TheWorks.co.uk plc
28th Sep 20237:00 amRNSInterim results for six months ended 30 June 2023
27th Sep 20239:52 amRNSTR-1: Notification of major holdings
26th Sep 20237:21 amRNSTR-1: Notification of major holdings
25th Sep 20237:00 amRNSNew Investment - TheWorks.co.uk plc
14th Sep 20234:16 pmRNSInvestment in THG Plc Update
20th Jul 20237:00 amRNSDirectors Dealings/PDMR Shareholding
13th Jul 20237:00 amRNSInvestment in THG Plc Update
12th Jul 20237:00 amRNSTrading Update
11th Jul 202311:14 amRNSTR-1: Notification of Major Holdings
27th Jun 202311:15 amRNSTR-1: Notification of Major Holdings
21st Jun 20239:04 amRNSTHG Trading Statement
8th Jun 20239:12 amRNSTR-1: Notification of Major Holdings
7th Jun 20239:44 amRNSTR-1: Notification of Major Holdings
31st May 20237:00 amRNSPlacing Admission Update
24th May 202312:00 pmRNSResult of AGM and Placing Update
19th May 20237:00 amRNSMello2023 Investor Conference
12th May 20233:45 pmRNSPublication of Prospectus and Placing Update
12th May 202310:23 amRNSTHG Update
2nd May 20237:00 amRNSAnnual Report and Notice of AGM
27th Apr 20237:30 amRNSResults of Placing
27th Apr 20237:15 amRNSFY22 Results and New Management Incentive Plan
21st Apr 20237:00 amRNSUpdate on THG Investment and Placing
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.